Shozo Nishida

Higashi-osaka, 5778502, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 102 publications

The Ethanol-Insoluble Low-Molecular-Weight Fraction LEP-4 Derived From Lentinula edodes Mycelia Extract Attenuates Oxaliplatin-Evoked Allodynia in Mice.

The Ethanol-Insoluble Low-Molecular-Weight Fraction LEP-4 Derived From Lentinula edodes Mycelia Extract Attenuates Oxaliplatin-Evoked Allodynia in Mice.

Journal: Advances in pharmacological and pharmaceutical sciences

Published: February 12, 2026

Association Between Body Mass Index and Hematotoxicity in Gynecological Cancer Patients Receiving Paclitaxel-Carboplatin Therapy: A Retrospective Study.

Association Between Body Mass Index and Hematotoxicity in Gynecological Cancer Patients Receiving Paclitaxel-Carboplatin Therapy: A Retrospective Study.

Journal: Cureus

Published: December 21, 2025

Comparison of Side Effects of Anti-epidermal Growth Factor Receptor (Anti-EGFR) Antibody Drugs During Initial Induction and Reinduction in Colorectal Cancer: A Case Series.

Comparison of Side Effects of Anti-epidermal Growth Factor Receptor (Anti-EGFR) Antibody Drugs During Initial Induction and Reinduction in Colorectal Cancer: A Case Series.

Journal: Cureus

Published: June 29, 2025

Overexpression of miR-29a and miR-29b is involved in imatinib resistance via abrogated NF1 expression and increased ERK1/2 activation in chronic myeloid leukemia cells.

Overexpression of miR-29a and miR-29b is involved in imatinib resistance via abrogated NF1 expression and increased ERK1/2 activation in chronic myeloid leukemia cells.

Journal: Medical oncology (Northwood, London, England)

Published: January 09, 2025

MDM2 inhibitors induce apoptosis by suppressing MDM2 and enhancing p53, Bax, Puma and Noxa expression levels in imatinib‑resistant chronic myeloid leukemia cells.

MDM2 inhibitors induce apoptosis by suppressing MDM2 and enhancing p53, Bax, Puma and Noxa expression levels in imatinib‑resistant chronic myeloid leukemia cells.

Journal: Biomedical reports

Published: October 10, 2024

Oxaliplatin and 5-fluorouracil promote epithelial-mesenchymal transition via activation of KRAS/ERK/NF-κB pathway in KRAS-mutated colon cancer cells.

Oxaliplatin and 5-fluorouracil promote epithelial-mesenchymal transition via activation of KRAS/ERK/NF-κB pathway in KRAS-mutated colon cancer cells.

Journal: Molecular and cellular biochemistry

Published: March 08, 2024

RANK/RANKL axis promotes migration, invasion, and metastasis of osteosarcoma via activating NF-κB pathway.

RANK/RANKL axis promotes migration, invasion, and metastasis of osteosarcoma via activating NF-κB pathway.

Journal: Experimental cell research

Published: January 24, 2024

Efficacy of palliative surgery for gastric cancer patients with peritoneal metastasis who still have residual peritoneal dissemination after chemotherapy.

Efficacy of palliative surgery for gastric cancer patients with peritoneal metastasis who still have residual peritoneal dissemination after chemotherapy.

Journal: Langenbeck's archives of surgery

Published: June 06, 2023

HER3/Akt/mTOR pathway is a key therapeutic target for the reduction of triple‑negative breast cancer metastasis via the inhibition of CXCR4 expression.

HER3/Akt/mTOR pathway is a key therapeutic target for the reduction of triple‑negative breast cancer metastasis via the inhibition of CXCR4 expression.

Journal: International journal of molecular medicine

Published: March 13, 2023

Activation of ERK1/2 by MOS and TPL2 leads to dasatinib resistance in chronic myeloid leukaemia cells.

Activation of ERK1/2 by MOS and TPL2 leads to dasatinib resistance in chronic myeloid leukaemia cells.

Journal: Cell proliferation

Published: November 28, 2022

Statins enhances antitumor effect of oxaliplatin in KRAS-mutated colorectal cancer cells and inhibits oxaliplatin-induced neuropathy.

Statins enhances antitumor effect of oxaliplatin in KRAS-mutated colorectal cancer cells and inhibits oxaliplatin-induced neuropathy.

Journal: Cancer cell international

Published: November 15, 2022

Efficacy of a Dexamethasone Dose Escalation Regimen with a Cumulative Dose for Preventing Oxaliplatin Hypersensitivity Reactions

Efficacy of a Dexamethasone Dose Escalation Regimen with a Cumulative Dose for Preventing Oxaliplatin Hypersensitivity Reactions

Journal: Gan to kagaku ryoho. Cancer & chemotherapy

Published: July 19, 2022

Showing 1-12 of 102

Last Updated: 09/26/2026